FMT

Pageonload-popup

Lifeblood FMT

On 20 September 2024, the Therapeutic Goods Administration (TGA) notified Lifeblood that our submission for Lifeblood Microbiota Transplant (faecal microbiota cryopreserved in glycerol) Suspension 150 g has been approved (AUST I 462465)

Intended use:

For the restoration of the gut microbiota in the management of gastrointestinal disorders. 

Additional conditions of inclusion:

Product must only be provided for use by a medical practitioner registered in an Australian state or territory, under the supervision or on the advice of a specialist gastroenterologist or infectious disease clinician. Product must not be released for use in conditions other than Clostridioides difficile infection, unless as part of a registered clinicial trial, via the Special Access Scheme or via the Authorised Prescriber Scheme

Microbiome_FMT_Product_Shot

How to order Lifeblood FMT

1

Download and fill out the order form below, and read and agree to the T&Cs

2

Email your completed form to MicrobiomeFMTOrdersWA@redcrossblood.org.au

3

We'll reach out to you to confirm delivery details and pricing

4

Your FMT order will be delivered by courier on dry ice

FMT terms and conditions thumbnail image

FMT Terms and Conditions

Please read this document prior to submitting the Microbiome-FMT order form.

Guide
Information Sheet
Microbiome - Lifeblood Faecal Microbiota Transplant (FMT) - Product Insert (Bottles)

Microbiome - Lifeblood Faecal Microbiota Transplant (FMT) - Product Insert (Bottles)

Information Sheet
microbiome order form image

Microbiome - FMT Order Form

Please ensure you read the associated Microbiome terms and conditions document prior to ordering.

Form

FAQs

Why order via Lifeblood?

Lifeblood has nearly 100 years of expertise in collecting and producing biological products in Australia. Our Microbiome program is just one of the many ways that Lifeblood supports all Australians through vital, life-giving biological products. 

How do I order via the TGA's Special Access Scheme?

Lifeblood FMT is available for patients with other indications outside of CDI, via the TGA's Special Access Scheme Application Pathway. This requires you to apply via their website portal, and approval is required before placing an order with Lifeblood. Once approval is confirmed, fill out our order form as normal and attach a copy of your TGA approval in an email to MicrobiomeFMTOrdersWA@redcrossblood.org.au.  

If you have any questions about this pathway, please contact us via email or call 1300 441 227.

What are your operating hours?

Our team is available to assist with email and phone enquiries and order processing from Monday to Friday from 8am-4pm AWST. Routine FMT orders can take 24-48 hours to arrive for metro locations. If you have an urgent order, please contact us to discuss your delivery options. 

What are the product and freight costs of ordering Lifeblood FMT?

Please email us at MicrobiomeFMTOrdersWA@redcrossblood.org.au or call us on 1300 441 227 to discuss pricing options with our team. 

How will my order arrive?

Lifeblood FMT will arrive via courier in a sealed plastic bag inside a container with dry ice alongside a data logger to record temperatures during transport. Further information about storing the product can be found in our Product Information Sheet above. 

How do I thaw and administer the product?

For detailed instructions on both colonoscopic and enema administration, please read our Product Information Sheet above. 

Where does the stool inside Lifeblood's FMT come from?

Our product is sourced from generous, voluntary and non-remunerated donors in Perth, Western Australia, and is compliant with TGO 105 guidelines.

Where is Lifeblood FMT manufactured?

Our product is manufactured to current Good Manufacturing Practices (cGMP) standards at the Microbiome Processing Centre within the Rotary WA Health Innovation Centre in Perth. 

Do you have a FMT capsule product?

Lifeblood is currently developing a liquid frozen FMT capsule, which should be available for clinical trials in early 2025. For more information, please contact us.

Latest news